Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) announced on October 27, 2026, that it will discontinue development of its AlloNK ...

The U.S. downgraded the importance of hypersonic missiles after initially investing in the weapons in the early 2000s.

The Opportunity Calgary Investment Fund (OCIF) will provide up to $1.5 million to The MindFuel Foundation over three years to strengthen Calgary's pipeline of future founders, innovation talent and ...

The Indiana Community Impact Accelerator will help with strategic planning, project management and capacity building for ...

ProJenX, a clinical-stage biotechnology company developing novel, targeted, brain-penetrant therapies for the treatment of amyotrophic lateral sclerosis (ALS) and other debilitating brain diseases, ...

The program’s first stage is complete, with all critical technologies reaching at least TRL 3 and a technology demonstrator ...

Rice University's fully funded Moody International Changemakers program sends STEM undergraduates to Latin America and ...

Artiva Biotherapeutics shares fell sharply Tuesday after the clinical-stage biotechnology company pulled the plug on lead development candidate AlloNK and said it would explore alternatives to ...

Keeping track of them is by far the cheapest and most important of the updates proposed for the program that allows the transfer of development rights from agricultural land to potential developers, ...

The second phase of the Mahaweli Water Security Investment Program has been planned to achieve the long-term objectives of ...

Explore how local needs are being identified and plans are being made to improve the social, economic, and environmental well ...

Rice’s Susanne M. Glasscock School of Continuing Studies is officially launching the Lifelong University program across all ...